James J Kim, MD in Buckhannon, WV - Orthopaedic Surgery

James J Kim, MD is a Orthopaedic Surgery physician based in Buckhannon, West Virginia. James J Kim is licensed to practice in West Virginia (license number 21129) and his current practice location is 1 Amalia Dr, Buckhannon, West Virginia. He can be reached at his office (for appointments etc.) via phone at (304) 473-6810.

NPI number for James J Kim is 1083619050 and his current mailing address is 1 Amalia Dr, Buckhannon, West Virginia. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1083619050.

Contact Information

	James J Kim, MD
	1 Amalia Dr, Buckhannon, WV 26201-2239
	(304) 473-6810
	(304) 473-6812

Physician's Profile

Full Name	James J Kim
Gender	Male
Speciality	Orthopaedic Surgery
Location	1 Amalia Dr, Buckhannon, West Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1083619050
Provider Enumeration Date: 06/16/2005
Last Update Date: 06/11/2009

Medical Identifiers

Medical identifiers for James J Kim such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1083619050	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207X00000X	Orthopaedic Surgery	21129 (West Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James J Kim is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
James J Kim, MD 1 Amalia Dr, Buckhannon, WV 26201-2239 Ph: (304) 473-6810	James J Kim, MD 1 Amalia Dr, Buckhannon, WV 26201-2239 Ph: (304) 473-6810

News Archive

IDEAL LM study: Biodegradable polymer everolimus-eluting stent safe and effective for patients undergoing PCI

New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a conventional durable polymer everolimus-eluting stent (DP-EES) followed by 12 months of DAPT in patients undergoing PCI for unprotected left main coronary artery (uLMCA) disease.

Johns Hopkins researchers reveal potential of AI in medical imaging and diagnostics

The advent of electronic medical records with large image databases, along with advances in artificial intelligence with deep learning, is offering medical professionals new opportunities to dramatically improve image analysis and disease diagnostics.

Children with craniofacial disorders face numerous medical challenges beyond appearance

Children born with cleft lip, cleft palate and other craniofacial disorders face numerous medical challenges beyond appearance.

Transplanting genetically modified adult stem cells into injured spinal cord increases movement recovery

Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical pathways associated with movement. The results are published in the Feb. 24 issue of the Journal of Neuroscience.

James J Kim, MD - Orthopaedic Surgery in Buckhannon, WV